Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Uniqure NV QURE

Healthcare Biotechnology
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington’s disease... see more

Current News (NDAQ:QURE)

QURE Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm

TheNewsWire 1 day ago

QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

GlobeNewswire 4 days ago

QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

GlobeNewswire 8 days ago

uniQure N.V. Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm

TheNewsWire 11 days ago

uniQure Announces Type A Meeting Scheduled with FDA

GlobeNewswire 11 days ago

QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

GlobeNewswire 13 days ago

QURE Investigation: Investors Encouraged to Contact Kirby McInerney LLP

Business Wire January 5, 2026

QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm

TheNewsWire January 4, 2026

QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm

TheNewsWire January 2, 2026
View More News ››

Opinion & Analysis (NDAQ:QURE)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:QURE)

Sell buddy sell.

Otherwise LOSO for shareholders today anyway,it is going down big-time today anyway
coolfooldumbguy - November 3, 2025

RE:UniQure N.V. (NASDAQ: QURE) – A Promising Gene Therapy

The space has some names that are interesting for various reasons right now - FDMT, Lexeo, for better or for worse Sarepta -
throwaway11 - September 25, 2025

Using technical analysis for this stock.

It is showing strength to the upside today for shareholders,so good luck to all of you guys
coolfooldumbguy - September 25, 2025

Buy buddy buy.

Otherwise FOMO
coolfooldumbguy - September 24, 2025

QURE.....this is the way a real deal works!!!!

Good News.....a financing ....volume & price Action Up huge on volume with NR and also on news of a Financing!!!!
Iseneschal - September 24, 2025

UniQure N.V. (NASDAQ: QURE) – A Promising Gene Therapy

http://beyondspx.com/2024/08/02/uniqure-n-v-nasdaq-qure-a-promising-gene-therapy-company-navigating-challenges/
MikeTester - August 3, 2024
View more Bullboard ››

Vesalius Longevity Labs

Vesalius Longevity Labs

View More »

Podcasts